In recent weeks, big tech companies have been lending their expertise, money and labor to the country’s COVID-19 vaccination effort. Below are 10 recent instances of big tech companies offering their assistance to the U.S. vaccine campaign: Amazon’s CEO of consumer business, Dave Clark, sent a letter to President Joe Biden shortly after he was sworn in offering the company’s help in distributing COVID-19 vaccines. Mr. Clark said Amazon would use its operations, IT and communications capabilities to help the government distribute vaccines and that the company had agreements with licensed third-party healthcare providers to administer vaccines on-site at Amazon facilities.
Author: Praveen Suthrum
Prior to the pandemic, physicians were already feeling burned out. Covid-19 has only added to the long hours, reluctance for technology adoption, and administrative burden facing physicians. Further, a recent survey found that nearly two-thirds of doctors also cited their long-standing problem with bureaucracy, and more than one-third pointed to long hours as contributing factors to a lack of work-life balance. The urgent need for the transition to value-based care from fee-for-service (FFS) only threatens to add to this burden. Health systems seeking to create a (VBC) strategy that has staying power need to ensure that physicians are engaged as part of…
As winter weather batters the Southern U.S., several ASCs are closed Feb. 16 for the safety of patients and staff. Here’s a list of ASCs or outpatient surgery centers that are closed today: Campbell Clinic in Memphis, Tenn., according to local NBC affiliate WMCLe Bonheur Outpatient Center in Memphis, according to local NBC affiliate WMCWabash Valley Surgery Center in Terre Haute, Ind., according to mywabashvalley.comNorth Mississippi Health Services’ Center for Digestive Health in Tupelo, Miss., according to the Northeast Mississippi Daily Journal
Healio Gastroenterology presents the following reports on the most recent research on the intersection of COVID-19 and gastroenterology. Gastroenterologists have been focused on the COVID-19 vaccine and how it may impact their patients, particularly those with inflammatory bowel disease. These reports also include new research on how the COVID-19 interacts with the microbiome and liver disease.
Amit Mehta, MD, a third-year gastroenterology fellow at New York-Presbyterian/Weill Cornell Medical Center, has a clear career goal in mind. “I’m hoping to focus on endobariatrics,” he said, referring to relatively new procedures that promote weight loss via endoscopy, such as endoscopic sleeve gastroplasty.
During a follow-up of 39 months, 32% of overweight or obese patients with nonalcoholic fatty liver disease achieved 5% or greater weight loss, according to results published in Clinical Gastroenterology and Hepatology. Twenty-five percent of these patients maintained 5% or greater weight loss.
After a decade studying a flu virus that killed approximately 15,000 Michigan residents, Chandra, a professor in the James Madison College at Michigan State University, saw his research come to life as he watched the spread of the COVID-19 pandemic.
Hospitals and health systems across the U.S. have accelerated digital transformation efforts in order to maintain communication and relationships with their patients while promoting safety from COVID-19. Here, nine hospital digital and innovation leaders share how they want health IT to continue innovating and adapting to the pandemic.
A Gastro Health-Alabama affiliate in Birmingham, is using Ambu’s single-use duodenoscope, the platform announced Feb. 10. Gastro Health is using the duodenoscope for endoscopic retrograde cholangiopancreatography procedures. Kenneth Sigman, MD, believes he is the first physician in the state to use the single-use device. The FDA approved Ambu’s single-use device in July 2020. Single-use duodenoscopes are gaining popularity due to contamination issues common with reusable duodenoscopes.
In this exclusive video, Uma Mahadevan, MD, from the University of California, San Francisco, discusses the upcoming GUILD conference.